High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention

Detalhes bibliográficos
Autor(a) principal: Yuksel, Uygar Cagdas
Data de Publicação: 2011
Outros Autores: Celik, Turgay, Celik, Murat, Bugan, Baris, Iyisoy, Atila, Yaman, Halil
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/19485
Resumo: OBJECTIVE: This retrospective study aimed to investigate the relationship between admission levels of serum y-glutamyltransferase and poor myocardial perfusion after primary percutaneous coronary intervention in patients with acute myocardial infarction. INTRODUCTION: Reperfusion injury caused by free radical release and increased oxidative stress is responsible for the pathophysiology of the no-reflow phenomenon in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Serum ϒ-glutamyltransferase is an established marker of increased oxidative stress. METHODS: The study population consisted of 80 patients (64 men and 16 women, mean age = 67.5 + 6.6 years) with thrombolysis in myocardial infarction 0/1 flow pre-procedurally. The patients were divided into two groups according to thrombolysis in myocardial perfusion grades that were assessed immediately following primary percutaneous coronary intervention. The two groups (group 1 and group 2) each consisted of 40 patients with thrombolysis in myocardial perfusion grades 0-1 and thrombolysis in myocardial perfusion grades 2-3, respectively. RESULTS: Admission pain to balloon time, ϒ-glutamyltransferase and creatine kinase-MB isoenzyme levels of group 1 patients were significantly higher than those of group 2 patients. Pain to balloon time, ϒ-glutamyltransferase, peak creatine kinase-MB isoenzyme, low left ventricular ejection fraction and poor pre-procedural thrombolysis in myocardial infarction grade were significantly associated with poor myocardial perfusion by univariate analysis. However, only pain to balloon time and ϒ-glutamyltransferase levels showed a significant independent association with poor myocardial perfusion by backward logistic regression analysis. Adjusted odds ratios were calculated as 4.92 for pain to balloon time and 1.13 for ϒ-glutamyltransferase. CONCLUSION: High admission ϒ-glutamyltransferase levels are associated with poor myocardial perfusion in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, particularly in patients with prolonged pain to balloon time.
id USP-19_e2aa13302516571f656c790014f3eea8
oai_identifier_str oai:revistas.usp.br:article/19485
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention Myocardial infarctionNo-reflow phenomenonGamma-glutamyltransferase OBJECTIVE: This retrospective study aimed to investigate the relationship between admission levels of serum y-glutamyltransferase and poor myocardial perfusion after primary percutaneous coronary intervention in patients with acute myocardial infarction. INTRODUCTION: Reperfusion injury caused by free radical release and increased oxidative stress is responsible for the pathophysiology of the no-reflow phenomenon in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Serum ϒ-glutamyltransferase is an established marker of increased oxidative stress. METHODS: The study population consisted of 80 patients (64 men and 16 women, mean age = 67.5 + 6.6 years) with thrombolysis in myocardial infarction 0/1 flow pre-procedurally. The patients were divided into two groups according to thrombolysis in myocardial perfusion grades that were assessed immediately following primary percutaneous coronary intervention. The two groups (group 1 and group 2) each consisted of 40 patients with thrombolysis in myocardial perfusion grades 0-1 and thrombolysis in myocardial perfusion grades 2-3, respectively. RESULTS: Admission pain to balloon time, ϒ-glutamyltransferase and creatine kinase-MB isoenzyme levels of group 1 patients were significantly higher than those of group 2 patients. Pain to balloon time, ϒ-glutamyltransferase, peak creatine kinase-MB isoenzyme, low left ventricular ejection fraction and poor pre-procedural thrombolysis in myocardial infarction grade were significantly associated with poor myocardial perfusion by univariate analysis. However, only pain to balloon time and ϒ-glutamyltransferase levels showed a significant independent association with poor myocardial perfusion by backward logistic regression analysis. Adjusted odds ratios were calculated as 4.92 for pain to balloon time and 1.13 for ϒ-glutamyltransferase. CONCLUSION: High admission ϒ-glutamyltransferase levels are associated with poor myocardial perfusion in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, particularly in patients with prolonged pain to balloon time. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1948510.1590/S1807-59322011001000010Clinics; Vol. 66 No. 10 (2011); 1729-1734 Clinics; v. 66 n. 10 (2011); 1729-1734 Clinics; Vol. 66 Núm. 10 (2011); 1729-1734 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19485/21548Yuksel, Uygar CagdasCelik, TurgayCelik, MuratBugan, BarisIyisoy, AtilaYaman, Halilinfo:eu-repo/semantics/openAccess2012-05-23T16:43:20Zoai:revistas.usp.br:article/19485Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T16:43:20Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
title High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
spellingShingle High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
Yuksel, Uygar Cagdas
Myocardial infarction
No-reflow phenomenon
Gamma-glutamyltransferase
title_short High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
title_full High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
title_fullStr High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
title_full_unstemmed High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
title_sort High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
author Yuksel, Uygar Cagdas
author_facet Yuksel, Uygar Cagdas
Celik, Turgay
Celik, Murat
Bugan, Baris
Iyisoy, Atila
Yaman, Halil
author_role author
author2 Celik, Turgay
Celik, Murat
Bugan, Baris
Iyisoy, Atila
Yaman, Halil
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Yuksel, Uygar Cagdas
Celik, Turgay
Celik, Murat
Bugan, Baris
Iyisoy, Atila
Yaman, Halil
dc.subject.por.fl_str_mv Myocardial infarction
No-reflow phenomenon
Gamma-glutamyltransferase
topic Myocardial infarction
No-reflow phenomenon
Gamma-glutamyltransferase
description OBJECTIVE: This retrospective study aimed to investigate the relationship between admission levels of serum y-glutamyltransferase and poor myocardial perfusion after primary percutaneous coronary intervention in patients with acute myocardial infarction. INTRODUCTION: Reperfusion injury caused by free radical release and increased oxidative stress is responsible for the pathophysiology of the no-reflow phenomenon in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Serum ϒ-glutamyltransferase is an established marker of increased oxidative stress. METHODS: The study population consisted of 80 patients (64 men and 16 women, mean age = 67.5 + 6.6 years) with thrombolysis in myocardial infarction 0/1 flow pre-procedurally. The patients were divided into two groups according to thrombolysis in myocardial perfusion grades that were assessed immediately following primary percutaneous coronary intervention. The two groups (group 1 and group 2) each consisted of 40 patients with thrombolysis in myocardial perfusion grades 0-1 and thrombolysis in myocardial perfusion grades 2-3, respectively. RESULTS: Admission pain to balloon time, ϒ-glutamyltransferase and creatine kinase-MB isoenzyme levels of group 1 patients were significantly higher than those of group 2 patients. Pain to balloon time, ϒ-glutamyltransferase, peak creatine kinase-MB isoenzyme, low left ventricular ejection fraction and poor pre-procedural thrombolysis in myocardial infarction grade were significantly associated with poor myocardial perfusion by univariate analysis. However, only pain to balloon time and ϒ-glutamyltransferase levels showed a significant independent association with poor myocardial perfusion by backward logistic regression analysis. Adjusted odds ratios were calculated as 4.92 for pain to balloon time and 1.13 for ϒ-glutamyltransferase. CONCLUSION: High admission ϒ-glutamyltransferase levels are associated with poor myocardial perfusion in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention, particularly in patients with prolonged pain to balloon time.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19485
10.1590/S1807-59322011001000010
url https://www.revistas.usp.br/clinics/article/view/19485
identifier_str_mv 10.1590/S1807-59322011001000010
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19485/21548
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 66 No. 10 (2011); 1729-1734
Clinics; v. 66 n. 10 (2011); 1729-1734
Clinics; Vol. 66 Núm. 10 (2011); 1729-1734
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222757339791360